Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Boston Scientific Corporation

Market Cap 67.78B 59.54B 54.87B 51.36B 96.23B 6,421B 97.85B 659B 255B 3,150B 254B 249B 10,949B P/E 2026 *
16.8x
P/E 2027 * 15.9x
Enterprise Value 74.94B 65.83B 60.66B 56.79B 106B 7,099B 108B 728B 282B 3,483B 281B 275B 12,106B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.08x
Free-Float
84.76%
Yield 2026 *
-
Yield 2027 * -
1 day-0.25%
1 week+1.62%
Current month-5.44%
1 month-20.75%
3 months-32.97%
6 months-52.48%
Current year-52.09%
1 week 44.05
Extreme 44.05
45.83
1 month 44.05
Extreme 44.05
58.14
Current year 44.05
Extreme 44.05
100.9
1 year 44.05
Extreme 44.05
109.5
3 years 44.05
Extreme 44.05
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 2011-10-31
Director of Finance/CFO 52 2025-06-29
Chief Tech/Sci/R&D Officer - 2009-08-31
Director TitleAgeSince
Chairman 61 2016-05-02
Director/Board Member 74 2014-02-28
Director/Board Member 74 2016-04-14
Date Insider Type Main position Quantity % Market Cap.
05-27Don

Chief Executive Officer

-386,755 0.0261%
05-19Buy

Director

1,770 0.0001%
05-19Buy

Director

2,250 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.31%+1.62%-56.13%-14.62% 67.78B
+4.66%+5.47%+20.42%-6.72% 174B
+1.31%+2.18%-21.43%+26.39% 143B
+4.62%+4.67%-5.78%-21.78% 127B
+3.85%+3.77%+18.59%+0.51% 50.07B
+0.48%+0.29%-25.91%-31.24% 43.84B
+4.36%+5.94%+11.97%+11.28% 35.78B
+4.10%+3.91%+6.97%+42.82% 35.07B
+2.65%+7.24%-8.89%-15.71% 28.99B
+2.96%+5.57%-23.15%-8.31% 27.62B
Average +2.89%-1.61%-8.33%-1.74% 73.3B
Weighted average by Cap. +3.05%-2.01%-6.09%-1.74%

Financials

2026 *2027 *
Net sales 21.59B 18.97B 17.48B 16.36B 30.66B 2,045B 31.17B 210B 81.24B 1,004B 81.06B 79.31B 3,488B 23.37B 20.53B 18.92B 17.71B 33.18B 2,214B 33.73B 227B 87.92B 1,086B 87.72B 85.83B 3,775B
Net income 3.88B 3.41B 3.14B 2.94B 5.5B 367B 5.6B 37.68B 14.59B 180B 14.55B 14.24B 626B 4.12B 3.62B 3.33B 3.12B 5.85B 390B 5.95B 40.03B 15.5B 191B 15.46B 15.13B 665B
Net Debt 7.16B 6.29B 5.8B 5.42B 10.16B 678B 10.34B 69.58B 26.94B 333B 26.87B 26.3B 1,156B 4.08B 3.58B 3.3B 3.09B 5.79B 386B 5.88B 39.62B 15.34B 189B 15.3B 14.97B 658B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
26-06-24 US$45.80 +0.44% 969,209
26-06-23 US$45.60 +2.86% 18,696,071
26-06-22 US$44.33 -2.12% 16,784,721
26-06-18 US$45.29 +0.76% 30,854,998
26-06-17 US$44.95 -4.20% 20,824,302
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
45.60USD
Average target price
75.86USD
Spread / Average Target
+66.35%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!